I think that, in an era where almost any medication is being looked at in relation to COVID, the lack of funding is not a good sign. BIT may well be negotiating behind the scenes of course - those talks are not transparent for obvious reasons.
Currently, almost all nations on the planet are opening up - a different strategy than a year ago. They are doing so as vaccination levels are now the vast majority of the population. People are still getting the virus but the number of hospitalisations seems to have plateaued. I think the virus will be around for years.
The playing field has changed since COVID arrived to a large extent. Antivirals are the key to treating the virus symptoms but (this won't be popular) maybe BIT has missed the boat and its compound may not be the chosen one.
I can't see that if is a novel and successful compound against the virus has been produced that it would not have secured significant financial support at this stage. I have been wrong in the past but I can't see any pointers at the moment.
Given the finacial situation for BIT, they will need to come up with a partnership by mid year - and that could be coming of course. There are going to be a lot of competitors claiming the samee goals and results as BIT in 2022.
- Forums
- ASX - By Stock
- BIT
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-48
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIT (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.1¢ |
Change
-0.001(4.55%) |
Mkt cap ! $18.94M |
Open | High | Low | Value | Volume |
2.2¢ | 2.2¢ | 2.1¢ | $950 | 45.22K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 400000 | 2.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.2¢ | 953557 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 400000 | 0.021 |
4 | 290162 | 0.020 |
11 | 2560325 | 0.019 |
11 | 1759636 | 0.018 |
5 | 584520 | 0.017 |
Price($) | Vol. | No. |
---|---|---|
0.022 | 953557 | 3 |
0.023 | 1449422 | 4 |
0.024 | 112849 | 1 |
0.025 | 150000 | 1 |
0.027 | 169508 | 3 |
Last trade - 10.19am 16/10/2024 (20 minute delay) ? |
Featured News
BIT (ASX) Chart |
The Watchlist
JBY
JAMES BAY MINERALS LIMITED
Andrew Dornan, Executive Director
Andrew Dornan
Executive Director
SPONSORED BY The Market Online